Jinhai Medical Technology (HKSE:02225) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Jinhai Medical Technology 5-Year EBITDA Growth Rate?

Jinhai Medical Technology's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.01.

During the past 12 months, Jinhai Medical Technology's average EBITDA Per Share Growth Rate was -80.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -49.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jinhai Medical Technology was 20.00% per year. The lowest was -49.10% per year. And the median was -6.90% per year.

Competitive Comparison of Jinhai Medical Technology's 5-Year EBITDA Growth Rate

For the Staffing & Employment Services subindustry, Jinhai Medical Technology's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jinhai Medical Technology's 5-Year EBITDA Growth Rate Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Jinhai Medical Technology's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jinhai Medical Technology's 5-Year EBITDA Growth Rate falls into.

Jinhai Medical Technology 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jinhai Medical Technology (HKSE:02225) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Jinhai Medical Technology 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jinhai Medical Technology's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhai Medical Technology (HKSE:02225) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Jinhai Medical Technology Ltd (HKSE:02225) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

31 Sungei Kadut Avenue, Singapore, SGP, 729660

Website

https://www.jin-hai.com.hk

Jinhai International Group Holdings Ltd is a Singapore-based company engaged in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services, IT services, and construction ancillary services including warehousing services, cleaning services, and building maintenance work in Singapore. It earns a vast majority of its revenues from the Manpower outsourcing and ancillary services segment.

Executives

Liu Lei	2101 Beneficial owner
Chen Guobao	2201 Interest of corporation controlled by you
Full Fortune International Co., Ltd.	2101 Beneficial owner
Jiang Xiahong	2202 Interest of your spouse

Jinhai Medical Technology (HKSE:02225) Headlines

No Headlines